Skip to main content
17428 search results for:

Tamoxifen 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Endometrial Cancer | News

    Tamoxifen

    Endometrial cancer
  2. 01-04-2024 | Tamoxifen | News

    Tamoxifen

    Elevated T4 and anaplastic thyroid cancer
  3. Open Access 07-05-2024 | Tamoxifen | Online First

    Combined treatment of All-trans retinoic acid with Tamoxifen suppresses ovarian cancer

    In the reproductive system of women, ovarian cancer is one of the most common malignant tumors. Ovarian cancer incidence and mortality rates vary globally and are influenced by many factors. In general, the incidence rate is higher in developed …

  4. 01-04-2024 | Tamoxifen | News

    Tamoxifen

    Pulmonary cryptococcosis
  5. 01-03-2024 | Tamoxifen | News

    Tamoxifen

    Oesophageal varix
  6. 27-04-2024 | Tamoxifen | Online First

    Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis

    Since the 1970s, tamoxifen has been one of the most effective and widely used anti-cancer drugs in patients with breast cancer [ 1 , 2 ]. Adjuvant tamoxifen therapy after primary surgical treatment markedly reduces the risk of recurrence of breast …

  7. 01-02-2024 | Tamoxifen | News

    Tamoxifen

    Severe acute necrotising pancreatitis
  8. Open Access 14-03-2024 | Tamoxifen | Online First

    Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?

    Tamoxifen, a cornerstone in the adjuvant treatment of estrogen receptor-positive breast cancer, significantly reduces breast cancer recurrence and breast cancer mortality; however, its standard adjuvant dose of 20 mg daily presents challenges due …

  9. Open Access 01-12-2024 | Tamoxifen | OriginalPaper

    Cre-LoxP and tamoxifen-induced deletion of ovarian quiescin sulfhydryl oxidase 2 showed disruption of ovulatory activity in mice

    The mouse quiescin sulfhydryl oxidase 2 (QSOX2) is a 77 kDa enzyme from the quiescin Q6/FAD (flavin adenine dinucleotide)-dependent sulfhydryl oxidase (QSOX) family. Depending on the species of origin and its physiological functions, the QSOX2 …

  10. 01-02-2024 | Tamoxifen | News

    Tamoxifen

    Retinopathy
  11. 01-02-2024 | Tamoxifen | News

    Tamoxifen

    Retinopathy
  12. Open Access 01-12-2024 | Tamoxifen | OriginalPaper

    Small molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance

    Breast cancer is a leading cause of cancer-related deaths in women worldwide. About 75% of breast cancers are estrogen receptor (ER) positive [ 1 ]. Tamoxifen, an antagonist of ERα66 (the classic estrogen receptor), is the most effective drug and …

  13. 01-01-2024 | Tamoxifen | News

    Tamoxifen

    Uterine adenosarcoma and endometrial clear cell carcinoma
  14. 01-12-2023 | Tamoxifen | News

    Tamoxifen

    Retinopathy
  15. 01-12-2023 | Tamoxifen | News

    Tamoxifen

    Uterine low grade endometrial stromal sarcoma, adenoid cystic carcinoma of the cervix and ovarian high grade serous carcinoma: 3 case report
  16. 01-11-2023 | Pancreatitis | News

    Tamoxifen

    Hyperlipidaemia leading to pancreatitis: 2 case reports
  17. 01-11-2023 | Tamoxifen | News

    Tamoxifen

    Endometrial adenocarcinoma, atrophic endometrium and submucous leiomyoma : 3 case reports
  18. 01-11-2023 | Vitrectomy | News

    Tamoxifen

    Macular hole: case report
  19. 10-11-2023 | Breast Cancer | OriginalPaper

    The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer

    Tamoxifen is a selective estrogen receptor modulator. In current clinical practice, tamoxifen is successfully used within the scope of adjuvant endocrine therapy in women with hormone receptor-positive breast cancer, either as a stand-alone …

  20. 01-10-2023 | Breast Cancer | News

    Tamoxifen

    Lack of efficacy: case report

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.